Brookdale Senior Living Inc. (BKD) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-03, Brookdale Senior Living Inc. (NYSE: BKD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $10.44 (+0.48% 1D, market cap $2.48B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, BKD ranks #711 in composite RQD confidence.
Within the Health Care sector (Hospital/Nursing Management), BKD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 26.2%, and ROIC of 0.3%. By comparison, MD (Pediatrix Medical Group Inc.) holds a B+ grade (77/100 RQD, P/E 14.3x, ROIC 33.6%, cap $2.33B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).
Per BKD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001332349), Brookdale Senior Living Inc. generated $3.19B in revenue (+2.2% YoY), -$262.7M in net income, and $16.5M in free cash flow against $5.95B in total assets and $4.22B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 0.5% FCF Margin ($16.5M FCF) & 26.2% Gross Margin
20D Institutional Volume Accumulation (±6.7% realized swing band)
Dilution Drag (+1.92% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
While BKD currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($11.00) and Max Pain ($10.96) forces dealer call-delta covering toward $17.94.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Brookdale Senior Living Inc. (BKD) advanced +0.48% to $10.44, trading at 27% of its 52-week range ($8.02 – $17.09). Stretched risk/reward at current multiples (0% return on capital) under elevated 10-year interest-rate pressure.
Yahoo! Finance Canada report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
PR Newswire report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
StockStory report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
October jobs report: election and inflation risks, sector winners, and top stock picks in health care, finance, manufacturing, and defense.
Antipodes Partners published its third-quarter 2026 investor letter for “Antipodes Global Fund.” The letter can be downloaded here. In Q3 2026, markets were volatile but broadly positive, with global equities rising 1.6%
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +2.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BKD today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BKD. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Brookdale Senior Living Inc. (BKD) ranks #711 by composite RQD confidence (32/100, grade E) and #220 by equity capitalization ($2.48B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with BKD at 32/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BKD
ACTIVE
Brookdale Senior Living Inc. | E | 32/100 | — | 26.2% | 0.3% | +0.48% | $2.48B | Benchmark Subject |
| MD Pediatrix Medical Group Inc. | B+ | 77/100 | 14.3x | — | 33.6% | +2.99% | $2.33B | /md-vs-bkd → |
| SGRY Surgery Partners Inc. | C+ | 66/100 | — | — | 9.9% | -0.39% | $3.04B | /sgry-vs-bkd → |
| NHC National HealthCare Corporation | B | 72/100 | 27.7x | — | 10.1% | -1.96% | $3.23B | /nhc-vs-bkd → |
| ARDT Ardent Health Inc. | C+ | 69/100 | 12.8x | — | 10.5% | -2.49% | $1.70B | /ardt-vs-bkd → |
In its most recent audited fiscal period (FY2025, filed 2025-12-31), Brookdale Senior Living Inc. (BKD) reported GAAP revenue of $3.19B (+2.2% vs. FY2024 revenue of $3.13B , and +5.9% cumulative change since FY2023) , GAAP net income of -$262.7M, operating cash flow of $218.0M, and free cash flow of $16.5M (+147.1% YoY). On the balance sheet, BKD closed FY2025 with $5.95B in total assets against $4.22B in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $3.19B | -$262.7M | $218.0M | $16.5M | $5.95B | $4.22B |
| FY2024 (FY) | 2024-12-31 | $3.13B | -$201.9M | $166.2M | -$35.1M | $6.34B | $4.02B |
| FY2023 (FY) | 2023-12-31 | $3.02B | -$189.0M | $162.9M | $162.9M | — | — |
As of 2026-11-03, Brookdale Senior Living Inc. (NYSE: BKD) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $10.44 (+0.48% 1D, market cap $2.48B). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, BKD ranks #711 in composite RQD confidence.
Within the Health Care sector (Hospital/Nursing Management), BKD carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of 26.2%, and ROIC of 0.3%. By comparison, MD (Pediatrix Medical Group Inc.) holds a B+ grade (77/100 RQD, P/E 14.3x, ROIC 33.6%, cap $2.33B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).
Per BKD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001332349), Brookdale Senior Living Inc. generated $3.19B in revenue (+2.2% YoY), -$262.7M in net income, and $16.5M in free cash flow against $5.95B in total assets and $4.22B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
BKD last traded at $10.44 (+0.48% on volume of 5,472,430 shares), positioning the stock -5.09% below its 50-day simple moving average ($11.00) and -21.56% below its 200-day simple moving average ($13.31). Across its 52-week range of $8.02 to $17.09, BKD sits at the 26.7% percentile with a 14-day RSI of 48.7 (NEUTRAL RANGE) and an implied next-earnings move of ±6.7% ($9.74 to $11.14).
Brookdale Senior Living Inc. (BKD) earns a live Roarable RQD composite score of 32/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $10.44 (+0.48% 1D, market capitalization $2.48B).
Brookdale Senior Living Inc. (BKD) is a NYSE-listed issuer in the Health Care sector, operating within the Hospital/Nursing Management industry (per the company profile).
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Brookdale Senior Living Inc. (BKD) reported $3.19B in annual revenue (up from $3.13B in FY2024, +2.2% YoY) and -$262.7M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($3.02B revenue, -$189.0M net income) through FY2025, BKD scaled operating cash flow to $218.0M and free cash flow to $16.5M, backed by $5.95B in total assets against $4.22B in total debt.
— The Butterfly Supply-Chain Graph records no upstream or downstream links, no sector correlations, and no proprietary signals for BKD.
Real-time company headlines, analyst actions, and sector developments for Brookdale Senior Living Inc. (BKD) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo! Finance Canada report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
PR Newswire report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Timothy Sykes report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
StockStory report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Brookdale Senior Living Inc. (BKD) market action, institutional positioning, and fundamental catalysts.
Here is why I am bullish on BKD here at $10.39: Recent headlines point to stronger occupancy results that could support a margin and cash-flow recovery from the current near-zero ROIC.. Compare BKD's 0.4% operating margin and 0.3% ROIC against the rest of Hospital/Nursing Management. As long as cash conversion holds up, dips toward $9.87 are getting bought.
@ForensicBear Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Hospital/Nursing Management. If gross margin (26.2%) holds, EPS grows into the multiple faster than bears think.
Careful chasing BKD at $10.39. Negative net income in every reported period, an Altman Z of 0.2, and a 34.6 EV/EBITDA leave little margin for error if the recovery stalls.. Gross margin is 26.2%, but operating margin is 0.4%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $8.00 on multiple compression.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Gideon Ashmere, Ellis Vennor, Tessa Rookmere, Soren Halewick, Iona Brackenford, Nadia Vellacrest, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Virtual Cash Arena account (100% free — no credit card required).